The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients

Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular diabetology Vol. 13; no. 1; p. 52
Main Authors Li, Gang, Lu, Wei-hua, Ai, Rong, Yang, Jian-hong, Chen, Fang, Tang, Zhong-zhi
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 24.02.2014
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes. The subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels. Average serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c. As a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus.
AbstractList Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes. The subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels. Average serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c. As a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus.
BACKGROUND: Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes. METHODS: The subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels. RESULTS: Average serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c. CONCLUSION: As a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus.
Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes.BACKGROUNDHypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes.The subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels.METHODSThe subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels.Average serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c.RESULTSAverage serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c.As a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus.CONCLUSIONAs a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus.
Author Yang, Jian-hong
Tang, Zhong-zhi
Ai, Rong
Li, Gang
Chen, Fang
Lu, Wei-hua
AuthorAffiliation 1 Emergency Department, Wuhan General Hospital of Guangzhou Military Command, Wu Luo Road, Hong Shan, Wuhan, China
3 Department of Medicine Laboratory, Wuhan General Hospital of Guangzhou Military Command, Wuhan, China
2 College of Foreign Language, Huazhong Agriculture University, Hongshan, Wuhan, Hubei 430070, China
AuthorAffiliation_xml – name: 2 College of Foreign Language, Huazhong Agriculture University, Hongshan, Wuhan, Hubei 430070, China
– name: 1 Emergency Department, Wuhan General Hospital of Guangzhou Military Command, Wu Luo Road, Hong Shan, Wuhan, China
– name: 3 Department of Medicine Laboratory, Wuhan General Hospital of Guangzhou Military Command, Wuhan, China
Author_xml – sequence: 1
  givenname: Gang
  surname: Li
  fullname: Li, Gang
– sequence: 2
  givenname: Wei-hua
  surname: Lu
  fullname: Lu, Wei-hua
– sequence: 3
  givenname: Rong
  surname: Ai
  fullname: Ai, Rong
– sequence: 4
  givenname: Jian-hong
  surname: Yang
  fullname: Yang, Jian-hong
– sequence: 5
  givenname: Fang
  surname: Chen
  fullname: Chen, Fang
– sequence: 6
  givenname: Zhong-zhi
  surname: Tang
  fullname: Tang, Zhong-zhi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24564828$$D View this record in MEDLINE/PubMed
BookMark eNp1Ustu1TAUtFARfcCaHfKSTWgcP2JvkKDiJVViU9aW7ZxwjRI72A5wf4D_6Y_0m3B7y1WL6OrYc-bMHGt8jA5CDIDQc9K-IkSKU8J63nSStQ2hDe8eoaM9cnDnfIiOc_7WtqSXgjxBhx3jgslOHqHfFxvACSZTfAx54xdsofwECDhDWme82S7xlzeND8PqvJ0Aj8aVmDC5usQmDNjFFINJW2xSgVqcmZwfvbsRxD5gk7fzUuJcAYfLdgHc4cGbalPvS0UhlPwUPR7NlOHZbT1BX96_uzj72Jx__vDp7M15YxnvSjOIUfRCWsqcoFKo1jjG2MApB0vpyKQUDpgSoKSSBGxrmTDG9VQNhitp6Al6vdNdVjvD4Kp3MpNekp_rG3Q0Xt_vBL_RX-MPTRWVqudV4O1OwPr4gMD9jouzvs5BX-egCdW8qyIvb7dI8fsKuejZZwfTZALENWvCW0Y47RSp1Bd3F94b_U2wEk53BJdizgnGPYVUu_pH_uPO_5lwvtzEVRf204NzfwCE_sQx
CitedBy_id crossref_primary_10_1161_ATVBAHA_119_312509
crossref_primary_10_3390_antiox11112183
crossref_primary_10_1007_s40620_022_01432_8
crossref_primary_10_1371_journal_pone_0301281
crossref_primary_10_1002_cbin_11811
crossref_primary_10_1080_15384101_2020_1788251
crossref_primary_10_1016_j_kint_2016_05_020
crossref_primary_10_1038_s41598_017_12833_2
crossref_primary_10_1038_s41598_024_79393_0
crossref_primary_10_3390_biom14121592
crossref_primary_10_3390_ijms18050950
crossref_primary_10_1210_clinem_dgad710
crossref_primary_10_1016_j_ijid_2017_05_010
crossref_primary_10_1080_17435390_2022_2083995
crossref_primary_10_1097_MD_0000000000033210
crossref_primary_10_1007_s00018_024_05486_8
crossref_primary_10_1186_s12872_015_0073_6
crossref_primary_10_1186_s12933_015_0221_4
crossref_primary_10_1007_s11102_021_01157_0
crossref_primary_10_1016_j_scib_2023_07_032
crossref_primary_10_1161_HYPERTENSIONAHA_121_18778
crossref_primary_10_18632_oncotarget_22467
crossref_primary_10_1016_j_cellsig_2021_110219
crossref_primary_10_1155_2021_6675548
crossref_primary_10_4236_jdm_2022_121007
crossref_primary_10_3390_antiox9100963
crossref_primary_10_1016_j_bone_2015_12_004
crossref_primary_10_1016_j_gene_2018_04_078
crossref_primary_10_1038_s41401_018_0055_1
crossref_primary_10_1177_0003319716662423
crossref_primary_10_1177_1708538120904297
crossref_primary_10_3390_nu15173749
crossref_primary_10_1186_s12933_015_0238_8
crossref_primary_10_3389_fphar_2024_1380326
crossref_primary_10_1093_ckj_sfac224
crossref_primary_10_1164_rccm_201512_2380OC
Cites_doi 10.2337/diabetes.49.9.1571
10.1007/s001250100001
10.1016/j.atherosclerosis.2013.01.018
10.1186/1475-2840-11-101
10.1159/000080086
10.1148/radiol.2273020369
10.1210/jc.2005-0991
10.1161/01.ATV.0000133194.94939.42
10.1371/journal.pone.0046562
10.1111/j.1525-139X.2007.00255.x
10.1148/radiol.2283021006
10.1007/PL00002027
10.1016/S0168-8227(01)00239-X
10.1381/0960892054222867
10.1161/CIRCULATIONAHA.110.974899
10.1124/mol.106.027029
10.7314/APJCP.2012.13.10.5143
10.1111/j.1600-0765.2012.01503.x
10.1006/cyto.1999.0533
10.1161/ATVBAHA.111.230904
10.1016/j.bone.2006.02.061
10.1128/MCB.00192-09
10.2337/db11-0174
10.1111/j.1600-0722.2008.00548.x
10.1017/S0029665109990206
10.1101/gad.180406.111
10.1038/ki.2008.644
10.1016/j.jcmg.2012.06.006
10.1097/01.ASN.0000145894.57533.C4
10.2337/dc11-0008
10.2337/diabetes.53.12.3226
10.1042/CS20000335
10.1056/NEJMra0910283
10.1161/ATVBAHA.111.233601
10.1002/bies.20254
10.7314/APJCP.2013.14.6.3851
10.1161/01.RES.0000249379.55535.21
10.1210/er.2003-0015
10.1016/j.atherosclerosis.2012.08.014
10.1007/s00125-011-2191-8
10.1186/1475-2840-12-161
10.1016/j.biocel.2004.08.012
ContentType Journal Article
Copyright Copyright © 2014 Li et al.; licensee BioMed Central Ltd. 2014 Li et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: Copyright © 2014 Li et al.; licensee BioMed Central Ltd. 2014 Li et al.; licensee BioMed Central Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1186/1475-2840-13-52
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1475-2840
EndPage 52
ExternalDocumentID PMC3938975
oai_biomedcentral_com_1475_2840_13_52
24564828
10_1186_1475_2840_13_52
Genre Journal Article
GroupedDBID ---
0R~
29B
2VQ
2WC
4.4
53G
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C1A
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
FRP
NPM
7X8
PPXIY
ABVAZ
AFGXO
AFNRJ
5PM
PJZUB
ID FETCH-LOGICAL-b452t-d6f6768b34c638690ac444d535eb33f4886ce496e98981eb0b46aac739da598a3
IEDL.DBID RBZ
ISSN 1475-2840
IngestDate Thu Aug 21 14:06:15 EDT 2025
Wed May 22 07:13:23 EDT 2024
Fri Jul 11 08:40:10 EDT 2025
Thu Jan 02 22:18:48 EST 2025
Thu Apr 24 23:05:40 EDT 2025
Tue Jul 01 04:19:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b452t-d6f6768b34c638690ac444d535eb33f4886ce496e98981eb0b46aac739da598a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1186/1475-2840-13-52
PMID 24564828
PQID 1504153291
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3938975
biomedcentral_primary_oai_biomedcentral_com_1475_2840_13_52
proquest_miscellaneous_1504153291
pubmed_primary_24564828
crossref_primary_10_1186_1475_2840_13_52
crossref_citationtrail_10_1186_1475_2840_13_52
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-02-24
PublicationDateYYYYMMDD 2014-02-24
PublicationDate_xml – month: 02
  year: 2014
  text: 2014-02-24
  day: 24
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Cardiovascular diabetology
PublicationTitleAlternate Cardiovasc Diabetol
PublicationYear 2014
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References 10.1186/1475-2840-13-52-B15
10.1186/1475-2840-13-52-B37
10.1186/1475-2840-13-52-B38
10.1186/1475-2840-13-52-B17
10.1186/1475-2840-13-52-B39
10.1186/1475-2840-13-52-B18
10.1186/1475-2840-13-52-B19
10.1186/1475-2840-13-52-B8
10.1186/1475-2840-13-52-B40
10.1186/1475-2840-13-52-B20
10.1186/1475-2840-13-52-B42
10.1186/1475-2840-13-52-B21
10.1186/1475-2840-13-52-B4
10.1186/1475-2840-13-52-B22
10.1186/1475-2840-13-52-B5
10.1186/1475-2840-13-52-B23
10.1186/1475-2840-13-52-B6
10.1186/1475-2840-13-52-B46
10.1186/1475-2840-13-52-B7
10.1186/1475-2840-13-52-B25
10.1186/1475-2840-13-52-B47
10.1186/1475-2840-13-52-B1
10.1186/1475-2840-13-52-B3
10.1186/1475-2840-13-52-B26
10.1186/1475-2840-13-52-B48
10.1186/1475-2840-13-52-B49
10.1186/1475-2840-13-52-B28
10.1186/1475-2840-13-52-B29
-
10.1186/1475-2840-13-52-B51
10.1186/1475-2840-13-52-B30
10.1186/1475-2840-13-52-B52
10.1186/1475-2840-13-52-B31
10.1186/1475-2840-13-52-B10
10.1186/1475-2840-13-52-B32
10.1186/1475-2840-13-52-B11
10.1186/1475-2840-13-52-B33
10.1186/1475-2840-13-52-B34
10.1186/1475-2840-13-52-B13
10.1186/1475-2840-13-52-B36
21757657 - Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):e55-71
11378214 - Diabetes Res Clin Pract. 2001 Jul;53(1):55-61
16046581 - J Clin Endocrinol Metab. 2005 Oct;90(10):5841-7
16887934 - Mol Pharmacol. 2006 Nov;70(5):1469-80
24188692 - Cardiovasc Diabetol. 2013;12:161
22304911 - Cell. 2012 Feb 3;148(3):399-408
15954094 - Bioessays. 2005 Jul;27(7):708-16
15561954 - Diabetes. 2004 Dec;53(12):3226-32
15155384 - Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1161-70
19698203 - Proc Nutr Soc. 2009 Nov;68(4):370-7
19145240 - Kidney Int. 2009 May;75(9):890-7
23058065 - JACC Cardiovasc Imaging. 2012 Oct;5(10):990-9
23886195 - Asian Pac J Cancer Prev. 2013;14(6):3851-4
19546236 - Mol Cell Biol. 2009 Aug;29(16):4467-83
24134530 - Cardiovasc Diabetol. 2013;12:149
19210137 - Curr Med Res Opin. 2009 Jan;25(1):39-45
19066318 - Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E333-42
21918209 - Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2169-71
23411040 - Atherosclerosis. 2013 Apr;227(2):250-8
15579497 - J Am Soc Nephrol. 2004 Dec;15(12):2959-64
23049707 - PLoS One. 2012;7(10):e46562
12869688 - Radiology. 2003 Sep;228(3):826-33
10463582 - Cancer Res. 1999 Aug 15;59(16):3915-8
21614571 - Diabetologia. 2011 Aug;54(8):1946-56
22900680 - Cardiovasc Diabetol. 2012;11:101
17374082 - Semin Dial. 2007 Mar-Apr;20(2):103-9
15978153 - Obes Surg. 2005 Jun-Jul;15(6):813-9
15308873 - Am J Nephrol. 2004 Jul-Aug;24(4):415-21
12958148 - FASEB J. 2003 Nov;17(14):2115-7
18705802 - Eur J Oral Sci. 2008 Aug;116(4):341-52
10969842 - Diabetes. 2000 Sep;49(9):1571-8
12728184 - Radiology. 2003 Jun;227(3):795-801
11724655 - Clin Sci (Lond). 2001 Dec;101(6):671-9
15618010 - Int J Biochem Cell Biol. 2005 Mar;37(3):535-40
23078882 - Atherosclerosis. 2012 Dec;225(2):432-7
15294885 - Endocr Rev. 2004 Aug;25(4):629-72
12742296 - J Am Coll Cardiol. 2003 May 7;41(9):1547-53
11479936 - Herz. 2001 Jun;26(4):245-51
11719828 - Diabetologia. 2001 Nov;44(11):1973-88
21398528 - Diabetes Care. 2011 May;34(5):1219-24
21873554 - Diabetes. 2011 Oct;60(10):2484-95
10704252 - Cytokine. 2000 Mar;12(3):246-52
22302938 - Genes Dev. 2012 Feb 1;26(3):259-70
21163451 - JACC Cardiovasc Imaging. 2010 Dec;3(12):1229-36
22905750 - J Periodontal Res. 2013 Feb;48(1):52-65
21323543 - N Engl J Med. 2011 Feb 17;364(7):656-65
22498325 - JACC Cardiovasc Imaging. 2012 Apr;5(4):367-9
11698256 - Am J Physiol Cell Physiol. 2001 Dec;281(6):C1971-7
17095733 - Circ Res. 2006 Nov 10;99(10):1044-59
22144573 - Circulation. 2011 Dec 20;124(25):2855-64
16616713 - Bone. 2006 Sep;39(3):513-22
19691832 - BMC Med Genet. 2009;10:79
23244125 - Asian Pac J Cancer Prev. 2012;13(10):5143-8
References_xml – ident: 10.1186/1475-2840-13-52-B15
  doi: 10.2337/diabetes.49.9.1571
– ident: 10.1186/1475-2840-13-52-B29
  doi: 10.1007/s001250100001
– ident: 10.1186/1475-2840-13-52-B25
  doi: 10.1016/j.atherosclerosis.2013.01.018
– ident: 10.1186/1475-2840-13-52-B23
  doi: 10.1186/1475-2840-11-101
– ident: 10.1186/1475-2840-13-52-B46
  doi: 10.1159/000080086
– ident: 10.1186/1475-2840-13-52-B20
  doi: 10.1148/radiol.2273020369
– ident: 10.1186/1475-2840-13-52-B34
  doi: 10.1210/jc.2005-0991
– ident: 10.1186/1475-2840-13-52-B1
  doi: 10.1161/01.ATV.0000133194.94939.42
– ident: 10.1186/1475-2840-13-52-B33
  doi: 10.1371/journal.pone.0046562
– ident: 10.1186/1475-2840-13-52-B3
  doi: 10.1111/j.1525-139X.2007.00255.x
– ident: 10.1186/1475-2840-13-52-B21
  doi: 10.1148/radiol.2283021006
– ident: 10.1186/1475-2840-13-52-B17
  doi: 10.1007/PL00002027
– ident: -
  doi: 10.1016/S0168-8227(01)00239-X
– ident: 10.1186/1475-2840-13-52-B49
  doi: 10.1381/0960892054222867
– ident: 10.1186/1475-2840-13-52-B10
  doi: 10.1161/CIRCULATIONAHA.110.974899
– ident: 10.1186/1475-2840-13-52-B28
  doi: 10.1124/mol.106.027029
– ident: 10.1186/1475-2840-13-52-B37
  doi: 10.7314/APJCP.2012.13.10.5143
– ident: 10.1186/1475-2840-13-52-B39
  doi: 10.1111/j.1600-0765.2012.01503.x
– ident: 10.1186/1475-2840-13-52-B42
  doi: 10.1006/cyto.1999.0533
– ident: 10.1186/1475-2840-13-52-B7
  doi: 10.1161/ATVBAHA.111.230904
– ident: -
  doi: 10.1016/j.bone.2006.02.061
– ident: 10.1186/1475-2840-13-52-B51
  doi: 10.1128/MCB.00192-09
– ident: 10.1186/1475-2840-13-52-B32
  doi: 10.2337/db11-0174
– ident: 10.1186/1475-2840-13-52-B40
  doi: 10.1111/j.1600-0722.2008.00548.x
– ident: 10.1186/1475-2840-13-52-B48
  doi: 10.1017/S0029665109990206
– ident: 10.1186/1475-2840-13-52-B52
  doi: 10.1101/gad.180406.111
– ident: 10.1186/1475-2840-13-52-B4
  doi: 10.1038/ki.2008.644
– ident: -
  doi: 10.1016/j.jcmg.2012.06.006
– ident: 10.1186/1475-2840-13-52-B18
  doi: 10.1097/01.ASN.0000145894.57533.C4
– ident: 10.1186/1475-2840-13-52-B13
  doi: 10.2337/dc11-0008
– ident: 10.1186/1475-2840-13-52-B30
  doi: 10.2337/diabetes.53.12.3226
– ident: 10.1186/1475-2840-13-52-B19
  doi: 10.1042/CS20000335
– ident: 10.1186/1475-2840-13-52-B26
  doi: 10.1056/NEJMra0910283
– ident: 10.1186/1475-2840-13-52-B8
  doi: 10.1161/ATVBAHA.111.233601
– ident: 10.1186/1475-2840-13-52-B5
  doi: 10.1002/bies.20254
– ident: 10.1186/1475-2840-13-52-B36
  doi: 10.7314/APJCP.2013.14.6.3851
– ident: 10.1186/1475-2840-13-52-B6
  doi: 10.1161/01.RES.0000249379.55535.21
– ident: 10.1186/1475-2840-13-52-B38
  doi: 10.1210/er.2003-0015
– ident: 10.1186/1475-2840-13-52-B11
  doi: 10.1016/j.atherosclerosis.2012.08.014
– ident: 10.1186/1475-2840-13-52-B31
  doi: 10.1007/s00125-011-2191-8
– ident: 10.1186/1475-2840-13-52-B22
  doi: 10.1186/1475-2840-12-161
– ident: 10.1186/1475-2840-13-52-B47
  doi: 10.1016/j.biocel.2004.08.012
– reference: 21757657 - Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):e55-71
– reference: 15155384 - Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1161-70
– reference: 10969842 - Diabetes. 2000 Sep;49(9):1571-8
– reference: 15954094 - Bioessays. 2005 Jul;27(7):708-16
– reference: 23078882 - Atherosclerosis. 2012 Dec;225(2):432-7
– reference: 19546236 - Mol Cell Biol. 2009 Aug;29(16):4467-83
– reference: 12958148 - FASEB J. 2003 Nov;17(14):2115-7
– reference: 17095733 - Circ Res. 2006 Nov 10;99(10):1044-59
– reference: 23058065 - JACC Cardiovasc Imaging. 2012 Oct;5(10):990-9
– reference: 19691832 - BMC Med Genet. 2009;10:79
– reference: 12869688 - Radiology. 2003 Sep;228(3):826-33
– reference: 11698256 - Am J Physiol Cell Physiol. 2001 Dec;281(6):C1971-7
– reference: 16616713 - Bone. 2006 Sep;39(3):513-22
– reference: 15579497 - J Am Soc Nephrol. 2004 Dec;15(12):2959-64
– reference: 19066318 - Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E333-42
– reference: 24134530 - Cardiovasc Diabetol. 2013;12:149
– reference: 16046581 - J Clin Endocrinol Metab. 2005 Oct;90(10):5841-7
– reference: 23049707 - PLoS One. 2012;7(10):e46562
– reference: 21163451 - JACC Cardiovasc Imaging. 2010 Dec;3(12):1229-36
– reference: 11724655 - Clin Sci (Lond). 2001 Dec;101(6):671-9
– reference: 19698203 - Proc Nutr Soc. 2009 Nov;68(4):370-7
– reference: 11719828 - Diabetologia. 2001 Nov;44(11):1973-88
– reference: 11378214 - Diabetes Res Clin Pract. 2001 Jul;53(1):55-61
– reference: 19210137 - Curr Med Res Opin. 2009 Jan;25(1):39-45
– reference: 16887934 - Mol Pharmacol. 2006 Nov;70(5):1469-80
– reference: 17374082 - Semin Dial. 2007 Mar-Apr;20(2):103-9
– reference: 21873554 - Diabetes. 2011 Oct;60(10):2484-95
– reference: 12728184 - Radiology. 2003 Jun;227(3):795-801
– reference: 19145240 - Kidney Int. 2009 May;75(9):890-7
– reference: 21398528 - Diabetes Care. 2011 May;34(5):1219-24
– reference: 23411040 - Atherosclerosis. 2013 Apr;227(2):250-8
– reference: 22144573 - Circulation. 2011 Dec 20;124(25):2855-64
– reference: 22900680 - Cardiovasc Diabetol. 2012;11:101
– reference: 22302938 - Genes Dev. 2012 Feb 1;26(3):259-70
– reference: 21323543 - N Engl J Med. 2011 Feb 17;364(7):656-65
– reference: 21918209 - Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2169-71
– reference: 15618010 - Int J Biochem Cell Biol. 2005 Mar;37(3):535-40
– reference: 15294885 - Endocr Rev. 2004 Aug;25(4):629-72
– reference: 21614571 - Diabetologia. 2011 Aug;54(8):1946-56
– reference: 11479936 - Herz. 2001 Jun;26(4):245-51
– reference: 15308873 - Am J Nephrol. 2004 Jul-Aug;24(4):415-21
– reference: 18705802 - Eur J Oral Sci. 2008 Aug;116(4):341-52
– reference: 23244125 - Asian Pac J Cancer Prev. 2012;13(10):5143-8
– reference: 24188692 - Cardiovasc Diabetol. 2013;12:161
– reference: 22498325 - JACC Cardiovasc Imaging. 2012 Apr;5(4):367-9
– reference: 22905750 - J Periodontal Res. 2013 Feb;48(1):52-65
– reference: 15978153 - Obes Surg. 2005 Jun-Jul;15(6):813-9
– reference: 23886195 - Asian Pac J Cancer Prev. 2013;14(6):3851-4
– reference: 10463582 - Cancer Res. 1999 Aug 15;59(16):3915-8
– reference: 15561954 - Diabetes. 2004 Dec;53(12):3226-32
– reference: 22304911 - Cell. 2012 Feb 3;148(3):399-408
– reference: 10704252 - Cytokine. 2000 Mar;12(3):246-52
– reference: 12742296 - J Am Coll Cardiol. 2003 May 7;41(9):1547-53
SSID ssj0017861
Score 2.248196
Snippet Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in...
BACKGROUND: Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is...
SourceID pubmedcentral
biomedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 52
SubjectTerms Asymptomatic Diseases
Biomarkers - blood
Coronary Vessels - diagnostic imaging
Coronary Vessels - metabolism
Cross-Sectional Studies
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - diagnostic imaging
Female
Humans
Hypoxia-Inducible Factor 1, alpha Subunit - blood
Male
Middle Aged
Original Investigation
Radiography
Vascular Calcification - blood
Vascular Calcification - diagnosis
Vascular Calcification - diagnostic imaging
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bitRAEG10BfFFvO94owQffMk6nb6kg4iIuCzC-OTAvjXVSYcJzGbGucDmB_wff8RvsrqT7Bp3ffExdCpNUlXpOunKOYy9dqLSSLghccZjIh1qSqlKEeYxhZjmmOmoQzb7qk_m8supOr2UA-of4PZaaBf0pOab5dH59_YDJfz7mPBGv-UyUwm9ZqcJFzTJTXaLlqUsyBnM5OWWQmY077l9rjEKpMCBWcUEWfbRr-_L8Yp1pQz9u5vyj-Xp-B6729eV8LELhPvshm8esNuzfuf8IftB8QCbofNtUa-h79ACisH9GSza9eq8xoQg-r6o3dJDp8QD_NdPwKaEIlAd4KaF2ATaAvk2tvPFC0LdAG7bs_VuFSlgIXzZhRS6L7t03NO3bh-x-fHnb59Okl6DIXFSpbuk1JUmROKELChTCUpjIaUslVCEwkVF6a8LL3Ptgw4l927qpEYsMpGXqHKD4jE7aFaNP2SgZaUd8qx0aCQBJVQSqXhUymjBU19N2LvRc7frjm_DBgbs8Qglow0OtMGBlgur0gk7Grxki57ePKhsLG2EOUZfNXhzYTDM9M9TXw1ut5R9YUsFG7_aby2V01QBiTTnE_akC4OLiw3xNGHZKEBG9zUeaepFZPgWOdWRmXr635bP2B2q7GT8914-Zwe7zd6_oOpp517GrPgN83ocsQ
  priority: 102
  providerName: Scholars Portal
Title The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients
URI https://www.ncbi.nlm.nih.gov/pubmed/24564828
https://www.proquest.com/docview/1504153291
http://dx.doi.org/10.1186/1475-2840-13-52
https://pubmed.ncbi.nlm.nih.gov/PMC3938975
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NatwwEB6aBEovpf_ZtF1U6KEXtyvr1_TUlIRQ2FBKA0svQrJl1rDxLvsD3RfI-_RF-kwdyfa23rSnXgzG0hhrNNZ8mtE3AK8dK6VF3JA47W3CnZVoUqVAzKNzNsqskrEO2fhSXlzxTxMx-U0WvRfBp1q-o1yJBH-io4QyFHEARylHPBeA-em3XcBA6YYatWvcsvj8RcDeyfZZf0G65WXuJ0v-sfqcP4D7rdtIPjR6fgh3fP0I7o7bwPhjuEF1k2WX2DatFqRNwCI4xTbXZLpdzL9XNkEEvskrN_OkKbRD6M8fxNYFyQOTgV1uSczx3BJUXczWiwJJVRO72l4v1vPI8ErCxi1JSbNxi_ctO-vqCVydn339eJG0JRYSx0W6TgpZSgQcjvEcDRGRss0554VgAkE2K9G6Ze55Jn0oM0m9Gzkurc0VyworMm3ZUzis57U_BiJ5KZ2lqnBWc8RBVnCLvqEQWjKa-nIA73vjbhYNnYYJBNf9J2hrJmjNBK0ZyoxIB_C205LJW_byUERjZiKK0fJ2hze7Dt2b_tn0Vad2g8YVIia29vPNyqC3jA4OSzM6gGfNNNgJCxFjjnh1AKo3QXrf1X9SV9NI4M0ydBOVOPmvEXkO99B54_F4PX8Bh-vlxr9EB2nthnCgJmoIR6dnl5-_DOM2A17HXA-j0fwCWRET4A
linkProvider BioMedCentral
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VIgGXimfZ8jISBy4pm_iRRJwAUS3Q7WkrVVysseNoI22zq31I7B_g__BH-E2MnWTVtHDiGCWxE8-MPZ898w3AG8NLhYQbIpM5jIRBRSZVSsI8meXDHFMV6pCNz9ToXHy9kBd7MOlyYWwvCrPZfwz7y8dX09FnYQ7vQscay8_Uu1ikMqL5dhjFnHq7BbdTKdOQ1fXx--5sIc0aFtXu4Zbw5y8NXEuCn_XXrhsO6fW4yisL1cl9OGg9TPah-ewHsOfqh3Bn3J6hP4KfpBls2cXATasFa2O1GGnj5pJNt4v5jwojAusbW5mZY01NHhb__sWwLpj1pAe43LIQDrplJOUQ2BcaZFXNcLW9XKzngQyW-T1elrBmjOm6JXJdPYbzk8-TT6OorcYQGSGTdVSoUhE2MVxYslkC1WiFEIXkkvA4L2kiUNaJXDlfkTJ2ZmiEQrQpzwuUeYb8CezX89o9BaZEqQzGaWEwEwSZUAokN1LKTPE4ceUA3vfGXS8a5g3tubD7d0gPtJea9lLTMdcyGcBxJyVtW6JzX29jpgPgydTNF97uXuh6-uejrzuxa7JDf7iCtZtvVpoca_KFeJLHAzhs1GDXmD9cFgRtB5D2FKT3X_07dTUNXN88J48ylUf_NSKv4O5oMj7Vp1_Ovj2De-TziZCVL57D_nq5cS_Ir1qbl8FM_gDeaiRE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VIlVcUHkvpWAkDlzSbuJXIk4tsCqPVgixUsXFsh1HG7HNRvuQ2D_A_-GP8Js6dpJV08KJW6L4oXhm7Pns8TcArwwthEbcEJnU6YgZLdCkCo6YJ7V0mGkpQh6y0zNxMmYfz_n5Foy7uzC2F4XZ7D-G_eWDq9fRp2EOxwf747DOi8b0U3EYM8kjnHCHUUyxu1twW3IufWKDr8ffN4cLMm1oVLvCLePPXxq4dgt-2l-8bnik1wMrr6xUo12427qY5KjRiXuw5ar7sHPaHqI_gF-oGmTeBcFNypq0wVoE1XF1QSbrevaz1BGi9ZUtzdSRJikPif_8JrrKifWsB3q-JiEedE1QzCGyLzRIyoroxfqiXs4CGyzxm7wkIc0g43vL5Lp4COPR-29vT6I2HUNkGE-WUS4KgeDEUGbRaBFVa8sYyznlCMhpgTOBsI5lwvmUlLEzQ8OE1lbSLNc8SzV9BNvVrHJPgAhWCKNjmRudMsRMmjONfiTnqaBx4ooBvOmNu6ob6g3lybD7X1ARlJea8lJTMVU8GcBBJyVlW6Zzn3BjqgLiScXNCq83Fbqe_ln0ZSd2hYboT1d05WarhULPGp0hmmTxAB43arBpzJ8uM8S2A5A9Ben9V_9LVU4C2TfN0KWU_Ol_jcgL2PnybqQ-fzj7tAd30Odj4VY-ewbby_nK7aNftTTPg5VcAlmoJA8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relationship+between+serum+hypoxia-inducible+factor+1%CE%B1+and+coronary+artery+calcification+in+asymptomatic+type+2+diabetic+patients&rft.jtitle=Cardiovascular+diabetology&rft.au=Li%2C+Gang&rft.au=Lu%2C+Wei-hua&rft.au=Ai%2C+Rong&rft.au=Yang%2C+Jian-hong&rft.date=2014-02-24&rft.pub=BioMed+Central&rft.eissn=1475-2840&rft.volume=13&rft.spage=52&rft.epage=52&rft_id=info:doi/10.1186%2F1475-2840-13-52&rft_id=info%3Apmid%2F24564828&rft.externalDocID=PMC3938975
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2840&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2840&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2840&client=summon